Status:
TERMINATED
Hemodynamic Instability Index: The Impact to Care With a New Predictive Indicator
Lead Sponsor:
Philips Healthcare
Collaborating Sponsors:
Philips Electronics Nederland B.V. acting through Philips CTO organization
Conditions:
Shock
Hemodynamic Instability
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Philips has developed a new algorithm, called Hemodynamic Instability Rules Based Advisor (HIRBA 2.0) system, for the prediction of hemodynamic instability in critically ill patients, who were not pre...
Eligibility Criteria
Inclusion
- All patients admitted to the study unit will be invited to participate in the study.
- Study subject has to stay in study unit for at least 12 hours.
Exclusion
- Patients who were discharged from study unit earlier then 12 hours after admission.
- Patients who are or become dependent on extracorporeal membrane oxygenation (ECMO) support.
Key Trial Info
Start Date :
March 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 18 2016
Estimated Enrollment :
127 Patients enrolled
Trial Details
Trial ID
NCT02185521
Start Date
March 1 2016
End Date
November 18 2016
Last Update
June 11 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University in St. Louis School of Medicine, Department of Surgery, Section of Acute and Critical Care Surgery
St Louis, Missouri, United States, 63110-1093
2
Alpert Medical School of Brown University, Rhode Island Hospital, Medical Intensive Care Unit
Providence, Rhode Island, United States, 02903